HSG completes majority investment in PeierTech

HSG has completed its acquisition of a controlling stake in PeierTech, a manufacturer of medical-grade nitinol materials and precision components. HSG holds approximately 80% of the company after the transaction, and existing management retains the remaining equity and will continue to run day-to-day operations.

HSG plans to introduce a market-based equity incentive program for key management. PeierTech CEO Amy Shen said HSG's support will help the company pursue its next phase of growth. HSG partner Steve Jia cited international expansion, operational improvements and market consolidation as opportunities.

Founded in 2002, PeierTech serves medical device manufacturers in more than 20 countries across cardiovascular, neurovascular, orthopedic and other applications.